Eptifibatide 188627-80-7

Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation. We are honored to be National High-tech Enterprise, Heilongjiang Province Small And Medium-Sized Sci-Tech Enterprise, Heilongjiang Province Innovation Center of Synthetic Peptide, Harbin Enterprise Technology Center. As well as a initiating and governing unit of Polypeptide Branch of China Biochemical and Pharmaceutical Industry Association. Founded in 2011, located in Harbin China. With registered capital 17.4291 million, covering an area of 23, 000 square meters, construction area 4, 000 square meters. Jixianglong has peptide drug production workshop and pilot workshop for neoantigen personalized tumor peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc. Principal Business: -API Production -API R&D technical support -Preparation R&D Technical support -Custom peptide service -Solid phase synthesizer production -Production of neoantigen personalized tumor polypeptide vaccine -Cosmetic peptide production & sales -Medical devices production & sales -Disinfection products production & sales Main Products: 10 items completed polypeptide API declared: Eptifibatide, Somatostatin, Terlipressin Acetate, Thymalfasin, Atosiban Acetate, Carbetocin, Oxytocin, Ganirelix Acetate, Octreotide Acetate, Cetrorelix Acetate. N items as researching reserve series: Teriparatide, Bivalirudin, Liraglutide, Nesiritide, Abaloparatide, Semaglutide, Personalized cancer neoantigen peptide vaccine, Anti peptide bacteriostatic spray, Peptide drug conjugate (PDC)